Back

Bioanalysis Zone announces winner of Rising Star Award 2022


Bioanalysis Zone, the knowledge hub for the bioanalytical industry, has named Shelby Barnett (Newcastle University; Newcastle, UK) the 2022 winner of the Bioanalysis Rising Star Award (BRSA; formerly the New Investigator Award).

The BRSA is an annual award that recognizes and promotes the work of talented early career scientists, offering researchers a springboard to help establish themselves in the exciting world of bioanalysis.

 

This year’s winner, Shelby Barnett, Post Doctorate working with Newcastle Cancer Centre Pharmacology Group at Newcastle University, was nominated by Professor Gareth Veal (Newcastle University), who commented: “Shelby has published multiple key publications in the past year, which highlight how bioanalytical work can directly impact patient treatment […] A superb example of how the appropriate translation of bioanalytical assay development can make a significant real-world impact and very much a future leader in this area.”

 

On receiving the award, Shelby commented: “I am delighted to be this year’s BRSA winner. Thank you to my family, friends, colleagues and fellow bioanalysis buffs that voted for me on this campaign. This award has given me a wonderful opportunity to showcase my work globally, and for that, I would like to thank the award sponsors.”

As the winner of the BRSA, Shelby will present her work at the 15th European Bioanalysis Forum (EBF) Open Symposium, held in Barcelona (Spain) on 16−18 November 2022. She also receives a 1-year subscription to Bioanalysis and US $1000, courtesy of award sponsors Waters Corporation (MA, USA), a leading provider of laboratory solutions and software in separations science, mass spectrometry and thermal analysis.

Amy White, Digital Editor, Bioanalysis Zone, added: “This year has been a positive move forward for the bioanalytical community after dealing with COVID-19⁠-related disruptions last year. Thus, it has been an honor to share more good news with the community and to celebrate the bioanalytical efforts of early career researchers. I would like to congratulate Shelby and all of this year’s nominees on their inspirational work.”

 

Shelby won the public vote after four finalists were shortlisted by the judges. The other finalists were Brendan Powers (Labcorp Drug Development, WI, USA), Ruixuan Gao (University of Illinois Chicago, IL, USA) and Ryan Johnson (Genentech, CA, USA).

Videos introducing the research of each finalist are available to view at www.bioanalysis-zone.com/awards.

Nominations are now being accepted for the 2023 Bioanalysis Rising Star Award – contact Amy White directly ([email protected]) to submit a nomination.

Further details on the 15th EBF Open Symposium can be found here.

About Bioanalysis Zone

Since launching in 2011, Bioanalysis Zone has attracted over 11,000 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research, exclusive interviews, webinars and commentaries. Join the Bioanalysis Zone Twitter and LinkedIn group for updates.

About Waters Corporation

Waters Corporation develops and manufactures advanced analytical and material science technologies for laboratory-dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio consists of three publishing imprints, Future Science, Future Medicine and Newlands Press. In addition to a core business of subscription and open access journal publishing, FSG develops specialist knowledge networks and content hubs, such as Bioanalysis Zone, enabling professionals to easily connect and collaborate with their peers in niche scientific fields.

—END—